We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Notice for olaratumab (rmc) (Eli Lilly Australia Pty Ltd)
Active ingredients
olaratumab (rmc)
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Therapeutic area
Oncology